Pinnacle Wealth Management Advisory Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Buy
4,018
+224
+6% +$18.8K 0.02% 361
2026
Q1
$304K Buy
3,794
+98
+3% +$8.08K 0.02% 408
2025
Q4
$315K Buy
+3,696
New +$303K 0.02% 394
2023
Q3
– Sell
-2,483
Closed -$234K – 327
2023
Q2
$234K Buy
2,483
+20
+0.8% +$1.74K 0.03% 287
2023
Q1
$204K Buy
+2,463
New +$194K 0.03% 300

Other funds holding EW

Pinnacle Wealth Management Advisory Group's EW Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group increased its Edwards Lifesciences (EW) stake by 5.9% in Q2 2026, buying an estimated $18.8K and bringing the position to 4,018 shares worth $363K. The position accounts for 0.02% of the portfolio, ranked #361.

Pinnacle Wealth Management Advisory Group first reported a position in EW in Q1 2023 and has held it in 5 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Pinnacle Wealth Management Advisory Group held 4,018 shares of Edwards Lifesciences worth $363K as of Q2 2026.
  • Pinnacle Wealth Management Advisory Group bought 224 Edwards Lifesciences shares in Q2 2026, an estimated $18.8K.
  • Edwards Lifesciences made up 0.02% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #361 holding.
  • Pinnacle Wealth Management Advisory Group first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 5 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.